Downregulation of β-TrCP1 by miR-135b results in increased stability of TAZ and enhanced transcriptional activation of Hippo pathway target genes, potentially driving NSCLC progression and metastasis (75). The gene discussed is BTRC; the disease is non-small cell lung carcinoma.